A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Hsieh
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- the Carle Foundation Hospital
Urbana, Illinois, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Ui Health Care Mission Cancer and Blood - Ankeny Clinic
Ankeny, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Ui Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, United States
- Miami Valley Hospital South
Centerville, Ohio, United States
- Miami Valley Hospital
Dayton, Ohio, United States
- Miami Valley Hospital North
Dayton, Ohio, United States
- Premier Blood and Cancer Center
Dayton, Ohio, United States
- Atrium Medical Center-Middletown Regional Hospital
Franklin, Ohio, United States
- Miami Valley Cancer Care and Infusion
Greenville, Ohio, United States
- Upper Valley Medical Center
Troy, Ohio, United States
- Parkland Memorial Hospital
Dallas, Texas, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- Ut Southwestern/simmons Cancer Center-Fort Worth
Fort Worth, Texas, United States
- Ut Southwestern Clinical Center at Richardson/plano
Richardson, Texas, United States
- Vcu Massey Cancer Center at Stony Point
Richmond, Virginia, United States
- Vcu Massey Comprehensive Cancer Center
Richmond, Virginia, United States
- Marshfield Medical Center-Ec Cancer Center
Eau Claire, Wisconsin, United States
- Marshfield Medical Center - Minocqua
Minocqua, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Dec 2022
- Primary completion
- 30 Sept 2026
- Completion
- 30 Sept 2026
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 88
- Registry id
- NCT05211323
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.